RLAY
RELAY THERAPEUTICS INC
CUSIP: 75943R102
RELAY THERAPEUTICS INC (RLAY) — institutional ownership and SEC 13F holdings data. Healthcare sector. Source: SEC EDGAR 13F filings.
About
Relay Therapeutics Inc. is a clinical-stage biotechnology company focused on transforming the drug discovery process by integrating computation and experimental methods. Its proprietary Dynamo platform targets specific protein motions to develop small molecule therapies for cancer and genetic diseases. By applying these advanced technologies, the company aims to create novel treatments for patients with unmet medical needs.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...